BostonGene’s comprehensive AI-powered platform integrates multiomics data to accelerate discovery, reduce development risk and advance precision oncology across all stages the R&D continuum The post BostonGene Receives Frost & Sullivan’s 2025 North American Enabling Technology Leadership Award for Redefining Precision Oncology with AI and Multiomics Innovation appeared first on Frost & Sullivan.
